The Patient Knows Best: PROs in RA Practice and Research
Advanced systems for measuring patient-reported outcomes can help improve care of patients with rheumatoid arthritis and inform clinical research.
Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Advanced systems for measuring patient-reported outcomes can help improve care of patients with rheumatoid arthritis and inform clinical research.
Patients with juvenile idiopathic arthritis achieved long-term disease control with subcutaneous tocilizumab treatment, without any new safety concerns, in an LTE study of two trials.
A prospective study found that 96% of patients with RA-ILD had at least one serious infection, which proved fatal in 65% of cases.
The use of orthopedic implants or tumor necrosis factor inhibitors doubled the risk for bone infections in patients with RA who had contracted S aureus bacteremia.
Substantial patient safety gaps regarding latent tuberculosis screening persist among new users of biologic or targeted synthetic DMARDs, suggested a nationwide cohort study.